BTAI vs SYK · rev $388.0K vs P/E 35, rev $6.59B
BioXcel Therapeutics Inc (BTAI) versus Stryker Corporation (SYK) — a side-by-side from cached financials, not a winner call.
BioXcel Therapeutics Inc (BTAI) is a drug manufacturers - specialty & generic company listed on US.
Stryker Corporation (SYK) is a medical devices company listed on NYSE.
Latest reported BTAI revenue for 2026-06-30 was $388.0K. Net income was -$27.4M. Revenue was up 88.3% from 2026-03-31 to 2026-06-30. BTAI currently screens at market cap $36.1M.
Latest reported SYK revenue for 2026-06-30 was $6.59B. Net income was $1.28B. Revenue was up 9.5% from 2026-03-31 to 2026-06-30. SYK currently screens at market cap $115.45B and trailing P/E 34.9.
BTAI currently screens at market cap $36.1M. SYK currently screens at market cap $115.45B and trailing P/E 34.9.
Not investment advice. Open the BTAI and SYK stock pages for the full models.
Not investment advice.